What is the level of liabilities of Instem this year?
Instem has a debt balance of 39.35 M GBP this year.
Instem Liabilities 2024
Instem Liabilities
39.35 M GBP
Ticker
INS.L
ISIN
GB00B3TQCK30
WKN
A1C7NS
In 2024, Instem's total liabilities amounted to 39.35 M GBP, a -10.32% difference from the 43.88 M GBP total liabilities in the previous year.
Instem Aktienanalyse
What does Instem do?
Instem PLC is a company specialized in providing software solutions for the health and life sciences. It is headquartered in Abingdon, Oxfordshire and operates internationally. The company was founded in 2000 and has been listed on the London Stock Exchange since 2004. Instem's business model is based on helping life science companies optimize and automate their workflows. They offer a wide range of software products tailored to the specific needs of their customers. This includes systems for documenting animal experiments, clinical data collection, and solutions for regulatory drug submissions. One of Instem's key divisions is the Preclinical Solutions Division, which helps life science companies effectively plan and conduct their preclinical studies. The products in this division support the creation of study protocols, planning experimental procedures, and documenting study results. Additionally, customers of the Preclinical Solutions Division can access assistance with data collection and analysis, as well as comprehensive consulting services. Another important division of Instem is the Clinical Solutions Division, which supports clinical research facilities in conducting clinical trials. Their solutions include clinical data collection, study monitoring, and data submission to regulatory authorities. The Clinical Solutions Division also provides support for quality control and the production of statistical reports. Instem is also active in other areas, such as in vitro diagnostics and chemical approval. In these fields, the company offers a range of software solutions that aid in data collection, analysis, and reporting. A key factor that sets Instem apart from its competitors is its close collaboration with the life science community. The company works closely with customers, regulatory agencies, and interest groups to ensure that its products meet industry requirements and standards. In addition, the company has established close relationships with leading clinical and research institutions worldwide. In summary, Instem PLC is a significant provider of software solutions for the health and life sciences. The company has experienced impressive growth in recent years and strengthened its position in key market segments. Instem is well positioned to continue benefiting from the increasing demand for software solutions in the health and life sciences industry. Instem ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Instem's Liabilities
Instem's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Instem's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Instem's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Instem's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Instem’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Instem stock
What were the liabilities of Instem compared to the previous year?
The liabilities of Instem have increased by -10.32% dropped compared to the previous year.
What are the consequences of high debt for investors of Instem?
High liabilities can pose a risk for investors of Instem, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Instem?
Low liabilities mean that Instem has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Instem affect the company?
An increase in liabilities of Instem can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Instem affect the company?
A decrease in the liabilities of Instem can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Instem?
Some factors that can influence the liabilities of Instem include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Instem so important for investors?
The liabilities of Instem are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Instem take to modify the liabilities?
To change its liabilities, Instem can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Instem pay?
Over the past 12 months, Instem paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Instem is expected to pay a dividend of 0 GBP.
What is the dividend yield of Instem?
The current dividend yield of Instem is .
When does Instem pay dividends?
Instem pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Instem?
Instem paid dividends every year for the past 0 years.
What is the dividend of Instem?
For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.
In which sector is Instem located?
Instem is assigned to the 'Health' sector.
Wann musste ich die Aktien von Instem kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Instem from 9/6/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 9/6/2024.
When did Instem pay the last dividend?
The last dividend was paid out on 9/6/2024.
What was the dividend of Instem in the year 2023?
In the year 2023, Instem distributed 0 GBP as dividends.
In which currency does Instem pay out the dividend?
The dividends of Instem are distributed in GBP.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Instem
Our stock analysis for Instem Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Instem Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
